4-Bromo-3,3,4,4-tetrafluorobutyl (3,3,4,4,5,5,6,6,6-nonafluorohexyl) carbonate CAS 1980035-10-6
Purity 97%+In StockPharmaceutical Standards
| CAS No. | 1980035-10-6 |
| Molecular Formula | C11H8BrF13O3 |
| Molecular Weight | 515.06 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
4-Bromo-3,3,4,4-tetrafluorobutyl (3,3,4,4,5,5,6,6,6-nonafluorohexyl) carbonate (CAS 1980035-10-6) is a high-purity pharmaceutical standards reference standard from CATO, an ISO 17034 accredited reference material producer. Molecular formula: C11H8BrF13O3. Molecular weight: 515.06 g/mol. Each batch is supplied with a Certificate of Analysis (COA).
Physical & Chemical Properties
| Molecular Formula | C11H8BrF13O3 |
| Molecular Weight | 515.06 g/mol |
| Purity | 97%+ |
| Storage | Store in a cool place (≤25°C), keep sealed and dry |
| Solubility (reference) | Soluble in methanol, ethanol, DMSO |
| Stability | Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 1.0 |
| CAS Registry Year (est.) | 1996 |
| Halogen Content | F/Br-containing |
Related Bromo Standards
- N-(2-Bromo-4-methylphenyl)-2-((4-(4-chlorophenyl)-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide (CAS 476483-87-1)
- N-(4-Bromo-2-methylphenyl)-2-((4-(4-chlorophenyl)-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide (CAS 476483-89-3)
- 6-Bromo-1-[(1S)-1-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2-methylpropyl]-7-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester (CAS 934161-52-1)
- 3-(7-Bromo-9,9-dimethyl-9H-fluoren-2-yl)-9-phenyl-9H-carbazole (CAS 1186644-43-8)
- 5-Bromo-4-((2,4-dichlorobenzyl)thio)-2-(methylthio)pyrimidine (CAS 6341-65-7)
- N-(2-Bromo-4,6-difluorophenyl)-2-((3-ethyl-4-oxo-3,4,5,6,7,8-hexahydrobenzo[4,5]thieno[2,3-d]pyrimidin-2-yl)thio)acetamide (CAS 578699-57-7)
- 9-Bromo-5-(4-bromophenyl)-2-(4-methoxyphenyl)-5,10b-dihydro-1H-benzo[e]pyrazolo[1,5-c][1,3]oxazine (CAS 303061-03-2)
- N-(3-bromo-2,6-dimethoxy-5-nitrobenzoyl)-N'-(2,3,4,5,6-pentafluorophenyl)urea (CAS 223580-83-4)
Recommended Standards
- Dacomitinib Impurity 20 (CAS CATO-C4X-208620)
- MK-571 (CAS 115104-28-4)
- (Z)-[2-(Benzenesulfonyl)-1-[2-(4-chlorophenyl)-4-methyl-1,3-thiazol-5-yl]ethylidene][(4-fluorophenyl)methoxy]amine (CAS 672950-32-2)
- 5-(tert-Butoxycarbonyl)-4,5,6,7-tetrahydroisothiazolo[4,5-c]pyridine-3-carboxylic acid (CAS 2494304-68-4)
- 2-methylcyclobutan-1-amine hydrochloride (CAS 1803586-78-8)
- (R)-Methyl 4-(2-((tert-butoxycarbonyl)amino)-3-methoxy-3-oxopropyl)benzoate (CAS 1391585-26-4)
- 3-(4-Isopropoxybenzyl)azetidine (CAS 1183724-87-9)
- 5-(Boc-amino)-2-bromothiazole (CAS 1094070-77-5)
- 5-[5-(Piperidin-4-yl)-1,2,4-oxadiazol-3-yl]-1,3-benzodioxole (CAS 849925-04-8)
- Neuropeptide Y, human (CAS 98264-90-5)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 13829788188 / jacky.chen@cato-chem.com